Global Infectious Disease Molecular Diagnostics Market 2015 - Business and Technological Trends in Major Markets

Aug 13, 2015, 12:10 ET from Research and Markets

DUBLIN, Aug. 13, 2015 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/vbd2sd/2015_global) has announced the addition of the "2015 Global Infectious Disease Molecular Diagnostics Market: Country Forecasts, Supplier Shares, Emerging Technologies and Competitive Landscape" report to their offering.

This new seven-country study contains 1,265 pages, 191 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years.

Report Highlights

  • Business and technological trends in major markets
  • Five-year test volume and sales forecasts
  • Market shares of leading competitors
  • Feature comparison of major analyzers
  • Strategic profiles of leading market players and start-up firms developing innovative products
  • Specific product and business opportunities for instrument and consumable suppliers.

Rationale

The infectious disease molecular diagnostics market is one of the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the infectious disease molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

Companies Mentioned

  • Abbott
  • Affymetrix
  • Agilent Technologies
  • Applied Gene Technologies
  • Arca Biopharma
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • bioMerieux
  • Bio-Rad
  • Biotest
  • Cepheid
  • CellMark Forenciscs/LabCorp
  • Decode Genetics
  • Diadexus
  • Eiken
  • Elitech Group
  • Enzo
  • Exact Sciences
  • Fujirebio
  • Grifols
  • Hologic/Gen-Probe
  • Illumina
  • Kreatech
  • Li-Cor Biosciences
  • Monogram Biosciences/LabCorp
  • Myriad Genetics
  • Ortho-Clinical Diagnostics
  • Perkin Elmer/Caliper
  • Proteome Sciences
  • Qiagen
  • Roche
  • Scienion

For more information visit http://www.researchandmarkets.com/research/vbd2sd/2015_global

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

SOURCE Research and Markets



RELATED LINKS

http://www.researchandmarkets.com